Provided by Tiger Fintech (Singapore) Pte. Ltd.

Health Catalyst, Inc.

4.16
+0.06001.46%
Post-market: 4.160.00000.00%16:20 EDT
Volume:535.11K
Turnover:2.24M
Market Cap:289.54M
PE:-3.59
High:4.29
Open:4.15
Low:4.06
Close:4.10
Loading ...
May 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Correspondence

Form CORRESP - Correspondence
Apr 23, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]